Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.73 +0.01 (+0.09%)
At close: Aug 20, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Debt Ratio (2024 - 2025)

Drugs Made In America Acquisition's (DMAA) quarterly Debt Ratio came in at 0.0 in Q1 2025, down 99.98% on a QoQ basis from 1.2 in Q4 2024.

Drugs Made In America Acquisition (DMAA) Debt Ratio (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMAA) has 2 years of Debt Ratio data on file, last reported at 0.0 in Q1 2025.

  • Quarterly Debt Ratio changed N/A year-over-year to 0.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.0 (changed N/A YoY) and the FY2024 annual result came in at 1.2, changed N/A from the prior year.
  • Debt Ratio eased to 0.0 in Q1 2025, from 1.2 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.2 in Q4 2024 to a low of 0.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Launch Two Acquisition 557.86 Mn 557.86 Mn - -
2 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - -
3 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - 0.00
4 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -
5 Aldel Financial 397.49 Mn 397.49 Mn - -
6 Gores Holdings X 381.05 Mn 380.85 Mn - -
7 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 0.01
8 Blue Water Acquisition Corp. III 342.12 Mn 342.08 Mn - -
9 Berto Acquisition 313.96 Mn 313.81 Mn - -
10 Drugs Made In America Acquisition 215.52 Mn 215.52 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 0.00
Dec 31, 2024 1.20